These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 28534379)

  • 41. In vivo dosimetry of high-dose-rate brachytherapy: study on 61 head-and-neck cancer patients using radiophotoluminescence glass dosimeter.
    Nose T; Koizumi M; Yoshida K; Nishiyama K; Sasaki J; Ohnishi T; Peiffert D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):945-53. PubMed ID: 15708279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radioactive seed implantation combined with prosthesis denture in treatment of oral and maxillofacial malignancy.
    Meng J; Meng QF; Gu QP; Si YM; Zheng H; Zhang J; Li ZP; Zhuang QW
    Cell Biochem Biophys; 2013; 67(3):1529-32. PubMed ID: 23709313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiparametric MRI and post implant CT-based dosimetry after prostate brachytherapy with iodine seeds: The higher the dose to the dominant index lesion, the lower the PSA bounce.
    Quivrin M; Loffroy R; Cormier L; Mazoyer F; Bertaut A; Chambade D; Martin E; Maingon P; Walker P; Créhange G
    Radiother Oncol; 2015 Nov; 117(2):258-61. PubMed ID: 26324019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125.
    Rustin GJ; Nelstrop AE; Crawford M; Ledermann J; Lambert HE; Coleman R; Johnson J; Evans H; Brown S; Oster W
    J Clin Oncol; 1997 Jan; 15(1):172-6. PubMed ID: 8996139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-dose-rate brachytherapy using molds for lip and oral cavity tumors.
    Unetsubo T; Matsuzaki H; Takemoto M; Katsui K; Hara M; Katayama N; Waki T; Kanazawa S; Asaumi J
    Radiat Oncol; 2015 Apr; 10():81. PubMed ID: 25888772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
    Order SE; Stillwagon GB; Klein JL; Leichner PK; Siegelman SS; Fishman EK; Ettinger DS; Haulk T; Kopher K; Finney K
    J Clin Oncol; 1985 Dec; 3(12):1573-82. PubMed ID: 2415692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Computed tomographic-guided iodine-125 interstitial implants for malignant thoracic tumors.
    Huang Q; Chen J; Chen Q; Lai Q; Cai S; Luo K; Lin Z
    Eur J Radiol; 2013 Nov; 82(11):2061-6. PubMed ID: 23830205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Application of (125)I seeds combined with biliary stent implantation in the treatment of malignant obstructive jaundice].
    Wang T; Liu S; Zheng YB; Song XP; Jiang WJ; Sun BL; Wang LG
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):228-31. PubMed ID: 26988831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
    Bekci TT; Senol T; Maden E
    J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy.
    Huo YR; Huang Y; Liauw W; Zhao J; Morris DL
    Anticancer Res; 2016 Mar; 36(3):1041-9. PubMed ID: 26976996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma.
    Ragde H; Elgamal AA; Snow PB; Brandt J; Bartolucci AA; Nadir BS; Korb LJ
    Cancer; 1998 Sep; 83(5):989-1001. PubMed ID: 9731904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis.
    Cho HY; Kyung MS
    Med Sci Monit; 2019 Feb; 25():1087-1092. PubMed ID: 30737365
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Kindts I; Stellamans K; Billiet I; Pottel H; Lambrecht A
    Strahlenther Onkol; 2017 Sep; 193(9):707-713. PubMed ID: 28488030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postoperative iodine-125 interstitial brachytherapy for the early stages of minor salivary gland carcinomas of the lip and buccal mucosa with positive or close margins.
    Wu WJ; Shao X; Huang MW; Lv XM; Zhang XN; Zhang JG
    Head Neck; 2017 Mar; 39(3):572-577. PubMed ID: 28075511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue polypeptide antigen, carcinoembryonic antigen, carbohydrate antigen, and CA125 levels as tumor markers in squamous cell carcinoma of the head and neck.
    Kuo WR; Lee KW; Ho KY; Tsai SM; Chiang FY; Juan KH
    Kaohsiung J Med Sci; 1999 Mar; 15(3):152-8. PubMed ID: 10224839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
    Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional dose metrics as predictors of biochemical failure and local recurrence after low-dose-rate prostate brachytherapy.
    Spadinger I; Chu J; Afsari Golshan M; Keyes M; Pickles T; Hamm J; Morris WJ
    Brachytherapy; 2015; 14(3):350-8. PubMed ID: 25638507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostate specific antigen levels after definitive irradiation for carcinoma of the prostate.
    Schellhammer PF; Schlossberg SM; el-Mahdi AM; Wright GL; Brassil DN
    J Urol; 1991 May; 145(5):1008-10; discussion 1010-1. PubMed ID: 1707987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [CT guided radioactive seed (125)I implantation in treating multiple bone metastasis].
    Zhang JQ; Huang XQ; Zhang J; Cai P; Chen W; Wang J; Zhou DQ; Zhang EQ
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2739-42. PubMed ID: 19080445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.